About Us

The Company

InfraRed Imaging Systems, Inc. (INRIS) is a medical imaging company whose first product, the VascularViewer™®, uses near infrared light (nIR) from a companion Disposable Light Source (DLS) to generate highly accurate, real-time images of veins and arteries (see images below). The intuitive and detailed imaging allows doctors and nurses to more accurately and efficiently insert needles and catheters for peripheral intravenous (PIVs) access and for arterial access procedures performed at the radial artery (in the wrist). Arterial access is required for blood gas analyses and placement of arterial lines. An increasing proportion of interventional cardiovascular procedures such as insertion of stents and balloons are being performed via the radial artery. Use of the VascularViewer™ will improve quality of care and reduce patient pain as well as reduce costs through reductions in 1) clinician time, 2) materials use, and 3) use of more complication- prone, expensive and advanced procedures. INRIS’s nIR technology is a platform on which INRIS intends to build a line of imaging products and companion disposables.


Vascular access is the most commonly performed invasive procedure in healthcare, with over 1.4 billion procedures estimated to be performed annually in the US. Industry and literature sources indicate that it takes on average 2.5 attempts in adults to successfully place a peripheral IV catheter. Missed “sticks” and outright failures increase hospital costs by increasing clinician labor and materials costs. Outright vascular access failure also requires the use of more advanced and expensive procedures to obtain vascular access, and these advanced procedures are associated with an increased likelihood of complications, including catheter related bacterial infections. Besides the life threatening nature and the costs of treating systemic infections, which range between $60,000 and $80,000 per patient, reimbursement of the hospital for patient care stops once a hospital-acquired infection is identified. Failed attempts (missed “sticks’) and outright failure to gain peripheral vascular access also adversely impact quality of care and increase patient pain, which adversely affects patients’ perceptions of the quality of their care.

Our Partners:

Ben Franklin Technology Partners – Lender


Business Support Solutions, LLC – Accounting


Enterprise Law Associates LLC – General Corporate Law<


Hasse & Nesbitt LLC – Intellectual Property Law


Newgate Capital Partners – Business Consultant and Shareholder



Point Source, Inc. – Manufacturer of Device

Laminin Medical Products

Laminin Medical Products – Manufacturer of DLS

Leave a Reply